Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethan S Sen

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Kidney International|January 25, 2017
Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease managementAgnieszka Bierzynska, Hugh J McCarthy, Katrina Soderquest, et al.
Rheumatology (Oxford, England)|January 20, 2026
Validating treat-to-target endpoints in childhood lupus: data-driven sensitivity analyses from the UK JSLE cohort studyChandni Sarker, Andrea L Jorgensen, Kukatharmini Tharmaratnam, et al.
Rheumatology (Oxford, England)|February 6, 2025
Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patientsChandni Sarker, Andrea L Jorgensen, Kukatharmini Tharmaratnam, et al.
Rheumatology Advances in Practice|October 15, 2025
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scopeStephanie F Ling, Joshua L Bennett, Vanessa J Reid, et al.
Rheumatology Advances in Practice|June 8, 2026
Holistic management of juvenile idiopathic arthritis across all ages: British Society for Rheumatology Guideline scopeSandrine Compeyrot-Lacassagne, Richard P Beesley, Lisa Bray, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Kidney International|January 25, 2017
Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease managementAgnieszka Bierzynska, Hugh J McCarthy, Katrina Soderquest, et al.
Rheumatology (Oxford, England)|January 20, 2026
Validating treat-to-target endpoints in childhood lupus: data-driven sensitivity analyses from the UK JSLE cohort studyChandni Sarker, Andrea L Jorgensen, Kukatharmini Tharmaratnam, et al.
Rheumatology (Oxford, England)|February 6, 2025
Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patientsChandni Sarker, Andrea L Jorgensen, Kukatharmini Tharmaratnam, et al.
Rheumatology Advances in Practice|October 15, 2025
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scopeStephanie F Ling, Joshua L Bennett, Vanessa J Reid, et al.
Rheumatology Advances in Practice|June 8, 2026
Holistic management of juvenile idiopathic arthritis across all ages: British Society for Rheumatology Guideline scopeSandrine Compeyrot-Lacassagne, Richard P Beesley, Lisa Bray, et al.
Pageof 4